Dysregulated myelopoiesis is identified as a driver of nutritionally acquired immunodeficiency that persists after refeeding and nutritional recovery, indicating exposure to food scarcity may be an ...

Clonal hematopoiesis is common and associated with adverse outcomes, particularly in patients with cancer. Although conventional cytotoxic therapies are known to drive clonal hematopoiesis, ...

A University of British Columbia student was recognized at the largest cancer conference in North America for her recent work identifying potential side effects of a promising cancer drug.

In this retrospective cohort study, the presence of tumor-infiltrating clonal hematopoiesis (TI-CH) was associated with an ...

Unexpected mutations in blood stem cells may help protect against Alzheimer’s disease. A new study published in the journal ...

New research suggests that specific changes in blood composition may help protect the brain and reduce the risk of developing ...

This process is called clonal hematopoiesis and it has been linked to a higher risk for conditions such as cardiovascular ...

This process is called clonal hematopoiesis and it has been linked to a higher risk for conditions such as cardiovascular disease, stroke, blood cancers like leukemia and chronic obstructive pulmonary ...

This process is called clonal hematopoiesis and it has been linked to a higher risk for conditions such as cardiovascular ...

A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset ...

This process is called clonal hematopoiesis and it has been linked to a higher risk for conditions such as cardiovascular ...

Scientists at St. Jude Children’s Research Hospital and University Health Network showed that the stage of B-cell development ...